These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
313 related articles for article (PubMed ID: 22843416)
1. Anti-aging effects of vitamin C on human pluripotent stem cell-derived cardiomyocytes. Kim YY; Ku SY; Huh Y; Liu HC; Kim SH; Choi YM; Moon SY Age (Dordr); 2013 Oct; 35(5):1545-57. PubMed ID: 22843416 [TBL] [Abstract][Full Text] [Related]
2. Effective Hypothermic Storage of Human Pluripotent Stem Cell-Derived Cardiomyocytes Compatible With Global Distribution of Cells for Clinical Applications and Toxicology Testing. Correia C; Koshkin A; Carido M; Espinha N; Šarić T; Lima PA; Serra M; Alves PM Stem Cells Transl Med; 2016 May; 5(5):658-69. PubMed ID: 27025693 [TBL] [Abstract][Full Text] [Related]
3. Functional improvement and maturation of human cardiomyocytes derived from human pluripotent stem cells by barbaloin preconditioning. Yang H; Zhong W; Hamidi MR; Zhou G; Liu C Acta Biochim Biophys Sin (Shanghai); 2019 Sep; 51(10):1041-1048. PubMed ID: 31518384 [TBL] [Abstract][Full Text] [Related]
4. Probing flecainide block of I Geng L; Kong CW; Wong AOT; Shum AM; Chow MZY; Che H; Zhang C; Yau KL; Chan CW; Keung W; Li RA Toxicol Lett; 2018 Sep; 294():61-72. PubMed ID: 29758359 [TBL] [Abstract][Full Text] [Related]
5. Cell death mechanisms of the anti-cancer drug etoposide on human cardiomyocytes isolated from pluripotent stem cells. Nemade H; Chaudhari U; Acharya A; Hescheler J; Hengstler JG; Papadopoulos S; Sachinidis A Arch Toxicol; 2018 Apr; 92(4):1507-1524. PubMed ID: 29397400 [TBL] [Abstract][Full Text] [Related]
6. Myosin light chain 2 marks differentiating ventricular cardiomyocytes derived from human embryonic stem cells. Luo XL; Zhang P; Liu X; Huang S; Rao SL; Ding Q; Yang HT Pflugers Arch; 2021 Jul; 473(7):991-1007. PubMed ID: 34031754 [TBL] [Abstract][Full Text] [Related]
7. A Universal and Robust Integrated Platform for the Scalable Production of Human Cardiomyocytes From Pluripotent Stem Cells. Fonoudi H; Ansari H; Abbasalizadeh S; Larijani MR; Kiani S; Hashemizadeh S; Zarchi AS; Bosman A; Blue GM; Pahlavan S; Perry M; Orr Y; Mayorchak Y; Vandenberg J; Talkhabi M; Winlaw DS; Harvey RP; Aghdami N; Baharvand H Stem Cells Transl Med; 2015 Dec; 4(12):1482-94. PubMed ID: 26511653 [TBL] [Abstract][Full Text] [Related]
8. Functional expression and pharmaceutical efficacy of cardiac-specific ion channels in human embryonic stem cell-derived cardiomyocytes. Kim HS; Yoon JW; Li H; Jeong GO; Park JJ; Shin SE; Jang IH; Kim JH; Park WS Sci Rep; 2017 Oct; 7(1):13821. PubMed ID: 29062050 [TBL] [Abstract][Full Text] [Related]
9. Stiff matrix induces switch to pure β-cardiac myosin heavy chain expression in human ESC-derived cardiomyocytes. Weber N; Schwanke K; Greten S; Wendland M; Iorga B; Fischer M; Geers-Knörr C; Hegermann J; Wrede C; Fiedler J; Kempf H; Franke A; Piep B; Pfanne A; Thum T; Martin U; Brenner B; Zweigerdt R; Kraft T Basic Res Cardiol; 2016 Nov; 111(6):68. PubMed ID: 27743117 [TBL] [Abstract][Full Text] [Related]
10. Advancing Cardiovascular Drug Screening Using Human Pluripotent Stem Cell-Derived Cardiomyocytes. Oh J; Kwon OB; Park SW; Kim JW; Lee H; Kim YK; Choi EJ; Jung H; Choi DK; Oh BJ; Min SH Int J Mol Sci; 2024 Jul; 25(14):. PubMed ID: 39063213 [TBL] [Abstract][Full Text] [Related]
11. Calcium homeostasis in human induced pluripotent stem cell-derived cardiomyocytes. Lee YK; Ng KM; Lai WH; Chan YC; Lau YM; Lian Q; Tse HF; Siu CW Stem Cell Rev Rep; 2011 Nov; 7(4):976-86. PubMed ID: 21614516 [TBL] [Abstract][Full Text] [Related]
12. Chemical-defined and albumin-free generation of human atrial and ventricular myocytes from human pluripotent stem cells. Pei F; Jiang J; Bai S; Cao H; Tian L; Zhao Y; Yang C; Dong H; Ma Y Stem Cell Res; 2017 Mar; 19():94-103. PubMed ID: 28110125 [TBL] [Abstract][Full Text] [Related]
13. Transcriptome dynamics of human pluripotent stem cell-derived contracting cardiomyocytes using an embryoid body model with fetal bovine serum. Jung KB; Son YS; Lee H; Jung CR; Kim J; Son MY Mol Biosyst; 2017 Jul; 13(8):1565-1574. PubMed ID: 28671202 [TBL] [Abstract][Full Text] [Related]
15. Cardiotoxicity evaluation using human embryonic stem cells and induced pluripotent stem cell-derived cardiomyocytes. Zhao Q; Wang X; Wang S; Song Z; Wang J; Ma J Stem Cell Res Ther; 2017 Mar; 8(1):54. PubMed ID: 28279214 [TBL] [Abstract][Full Text] [Related]
16. Maturation of Pluripotent Stem Cell-Derived Cardiomyocytes: a Critical Step for Drug Development and Cell Therapy. Tan SH; Ye L J Cardiovasc Transl Res; 2018 Oct; 11(5):375-392. PubMed ID: 29557052 [TBL] [Abstract][Full Text] [Related]
17. Development of a novel two-dimensional directed differentiation system for generation of cardiomyocytes from human pluripotent stem cells. Moon SH; Ban K; Kim C; Kim SS; Byun J; Song MK; Park IH; Yu SP; Yoon YS Int J Cardiol; 2013 Sep; 168(1):41-52. PubMed ID: 23044428 [TBL] [Abstract][Full Text] [Related]
18. Promotion of maturation of human pluripotent stem cell-derived cardiomyocytes via treatment with the peroxisome proliferator-activated receptor alpha agonist Fenofibrate. Lee SG; Rhee J; Seok J; Kim J; Kim MW; Song GE; Park S; Jeong KS; Lee S; Lee YH; Jeong Y; Kim CY; Chung HM Stem Cells Transl Med; 2024 Aug; 13(8):750-762. PubMed ID: 38946019 [TBL] [Abstract][Full Text] [Related]